Propel Bio Management »

Immunic shares owned by Propel Bio Management

Quarter-by-quarter ownership of Immunic (IMUX) shares owned by Propel Bio Management from 13F filings

Historical chart of Propel Bio Management investment in Immunic

Tip: Access up to 7 years of quarterly data

All positions including Immunic held by Propel Bio Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunic by Propel Bio Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $5.0M 325k 15.37

More positions owned by Propel Bio Management

Plains Gp Holdings Lp-cl Comm (PAGP)
Achieve Life Sciences Comm (ACHV)
Corcept Therapeutics Comm (CORT)
Phathom Pharmaceuticals I Comm (PHAT)
Delcath Systems Comm (DCTH)
Milestone Pharmaceuticals Comm (MIST)
Compass Pathways Adrs (CMPS)
Kyverna Therapeutics Comm (KYTX)
Artiva Biotherapeutics In Comm (ARTV)
Abeona Therapeutics Comm (ABEO)
Aquestive Therapeutics In Comm (AQST)
Palisade Bio Comm (PALI)
Immunic Comm (IMUX)
Inventiva Sa - Comm (IVA)
Sab Biotherapeutics Comm (SABS)

View all positions for Propel Bio Management

Top funds holding Immunic

Standard Life Aberdeen
BVF
Millennium Management
Avidity Partners Management
Braidwell
Laurion Capital Management
Vanguard Capital Management
Woodline Partners
Soleus Capital Management
Propel Bio Management
Susquehanna International
Nantahala Capital Management
UBS Group
Geode Capital Management
683 Capital Management

View all funds holding Immunic